Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)

NCT02624063 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Daclatasvir + Sofosbuvir
DRUG: Simeprevir + Sofosbuvir

Sponsor

Federal University of São Paulo